Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(494)
•••
Post by FactFinder1994on Feb 27, 2023 7:31pm
127 Views
Post# 35308428

SQI LinkedIn Post last week.

SQI LinkedIn Post last week. Standard rapid antigen tests offer a cheap way to test individuals for COVID-19, but the cheaper option doesn’t always save you money.

When an outbreak of COVID-19 occurs in long-term care homes, there can be a huge cost to your business for both staff and resident sickness.

Invest in the health and wellbeing of your residents and staff with SQI Diagnostics and SOFIA2. Our Flu and COVID-19 Antigen Test offers high clinical sensitivity for flu A (97%), flu B (90%) and SARS-CoV-2 (95%), providing you with a premium, automated diagnostic tool for the early detection of active infections of both COVID-19 and flu.

Avoid misdiagnosis and maintain a high standard of care for your residents and staff by implementing these advanced testing protocols in your long-term care home.

Get in touch with us to book a free, no obligation demo today to learn more about our rapid, accurate covid and flu testing solutions: https://lnkd.in/gHXsXGhV

                                                                   COVID-19 and Flu Testing for Care Homes - SQI Diagnostics sqidiagnostics.com • 1 min read                                                    
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities